Pancreatic Cancer Research

ResearcherAbramson Cancer CenterNo recent work listed

Jinyang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8125-6603; OpenAlex author ID A5100320426. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper

Papers 9

  1. Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells. Co-author DOI 10.1158/1541-7786.mcr-22-0602↗
  2. Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-22-0431↗
  3. MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-20-1826↗
  4. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-20-0519↗
  5. PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Co-author DOI 10.1158/2159-8290.cd-20-1098↗
  6. Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. First author DOI 10.1016/j.jcmgh.2020.04.016↗
  7. Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. Co-author DOI 10.1016/j.xcrm.2020.100131↗
  8. Tumor Cell-Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-19-0661↗
  9. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. Co-author DOI 10.1053/j.gastro.2019.05.004↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ben Z. Stanger · 9 shared papers, 2019–2023 · strength 1.00
  2. Robert J. Norgard · 6 shared papers, 2020–2022 · strength 0.68
  3. Jason Robert Pitarresi · 4 shared papers, 2020–2023 · strength 0.45
  4. Salina Yuan · 3 shared papers, 2020–2022 · strength 0.36
  5. Yogev Sela · 2 shared papers, 2021–2022 · strength 0.24
  6. Anil K. Rustgi · 2 shared papers, 2021–2023 · strength 0.24
  7. Faiyaz Notta · 2 shared papers, 2021–2022 · strength 0.20
  8. Wells S. Brown · 2 shared papers, 2019–2020 · strength 0.18
  9. Paul C. McDonald · 2 shared papers, 2019–2020 · strength 0.18
  10. David F. Schaeffer · 2 shared papers, 2019–2020 · strength 0.18
  11. Daniel John Renouf · 2 shared papers, 2019–2020 · strength 0.18
  12. Shoukat Dedhar · 2 shared papers, 2019–2020 · strength 0.18
  13. Jinyun Chen · 1 shared paper, 2023 · strength 0.14
  14. Noreen McBrearty · 1 shared paper, 2023 · strength 0.14
  15. Edna Cukierman · 1 shared paper, 2023 · strength 0.14
  16. Serge Y Fuchs · 1 shared paper, 2023 · strength 0.14
  17. Igor A. Astsaturov · 1 shared paper, 2023 · strength 0.14
  18. Colin S. Sheehan · 1 shared paper, 2022 · strength 0.13
  19. Ian A. Blair · 1 shared paper, 2022 · strength 0.13
  20. Alexander Muir · 1 shared paper, 2022 · strength 0.13
  21. Maimon E. Hubbi · 1 shared paper, 2022 · strength 0.13
  22. Chi Van Dang · 1 shared paper, 2022 · strength 0.13
  23. Yanqing Jiang · 1 shared paper, 2021 · strength 0.11
  24. Robert H. Vonderheide · 1 shared paper, 2021 · strength 0.11
  25. Todd W. Ridky · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.